Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives

NCT ID: NCT04110353

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-30

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates whether specialist negative pressure dressings reduce the risk of wound infections after operations when compared to conservative dressings, and if one negative pressure dressings works better than another. The study will look at patients who have had an open operation on their bowel and the wound closed at the end of the operation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Surgical site infections (SSI) can affect up 41% of patients post-operatively. They are associated with significant healthcare and patient costs, and increased patient morbidity and mortality.

Specialist post operative dressings with negative pressure wound therapy are available, and the WHO do recommended for use in high risk wounds, taking resources into account. However no further recommendations are available.

This study will explore the rate of post-operative wound infections in adult patients undergoing open abdominal surgery on the bowel, and compare the rate of wound infections in these patients in relation to three different dressing types used after their operation. The study aims to determine if any of the dressings used within the study are associated with lower post-operative wound infection rates, and compare the overall costs of using each dressing type, including both direct healthcare costs and societal costs. Finally, it will evaluate participant's quality of life outcomes after open abdominal surgery, specifically relating to their wound.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wound Infection Surgical Site Infection Surgical Wound Surgical Incision

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Stepped wedge design with randomisation at the level of the Hospitals not individual patients
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conservative dressings

Use of simple dressings on wound post operatively - to be placed at end of operation

Group Type ACTIVE_COMPARATOR

Wound dressings: Conservative dressings

Intervention Type OTHER

Conservative dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

Prevena dressing

Use of Prevena(KCI) dressing on wound post operatively - to be placed at end of operation

Group Type ACTIVE_COMPARATOR

Wound dressings: Prevena dressings

Intervention Type OTHER

Prevena dressing to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

ciVAC dressing

Use of closed incision VAC (vacuum assisted closure) dressing on wound post operatively - to be placed at end of operation

Group Type ACTIVE_COMPARATOR

Wound dressings: ciVAC dressings

Intervention Type OTHER

Closed incision VAC dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wound dressings: Conservative dressings

Conservative dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

Intervention Type OTHER

Wound dressings: Prevena dressings

Prevena dressing to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

Intervention Type OTHER

Wound dressings: ciVAC dressings

Closed incision VAC dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Emergency, trauma or elective contaminated abdominal operations within general surgery and/or colorectal surgery
* Abdominal wounds closed at time of operation and expected to heal by primary intention
* Patients who have the capacity to consent
* To include complex abdominal wounds with existing infection where wounds have been closed and expected to heal by primary intention
* To including graft or flap sites as part of general surgical procedure
* Patients who are able to complete questionnaires post operatively, either alone or with assistance

Exclusion Criteria

* Wounds where an appropriate seal cannot be obtained
* Wounds left open and expected to heal by secondary intention
* Patients known to have allergy or sensitivity to dressings being used
* Patients who lack the capacity to consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Imperial College London

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christopher Peters

Role: PRINCIPAL_INVESTIGATOR

Imperial College London

Carolynne Vaizey

Role: STUDY_CHAIR

St Mark's Hospital and Academic Institute

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19IC5400

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VAC NPWT KCI Dressing Study
NCT01366105 WITHDRAWN NA